These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35691611)

  • 21. Trends in Adjuvant External Beam Radiation Therapy for Nonanaplastic Thyroid Cancer in California, 2003-2017.
    Hu MY; Chin RK; Kim J; Tseng CH; Yeh MW; Livhits MJ; Leung AM; Wu JX
    Endocr Pract; 2022 Jul; 28(7):647-653. PubMed ID: 35231653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of external beam radiotherapy in the treatment of papillary thyroid cancer.
    Lee N; Tuttle M
    Endocr Relat Cancer; 2006 Dec; 13(4):971-7. PubMed ID: 17158749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer.
    Saeed NA; Kelly JR; Deshpande HA; Bhatia AK; Burtness BA; Judson BL; Mehra S; Edwards HA; Yarbrough WG; Peter PR; Holt EH; Decker RH; Husain ZA; Park HS
    Head Neck; 2020 May; 42(5):1031-1044. PubMed ID: 32011055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.
    Schwartz DL; Lobo MJ; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Evans DB; Clayman G; Sherman SI; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1083-91. PubMed ID: 19095376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
    Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
    Wu SS; Lamarre ED; Yalamanchali A; Brauer PR; Hong H; Reddy CA; Yilmaz E; Woody N; Ku JA; Prendes B; Burkey B; Nasr C; Skugor M; Heiden K; Chute DJ; Knauf JA; Campbell SR; Koyfman SA; Geiger JL; Scharpf J
    JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):300-309. PubMed ID: 36757708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society.
    Kiess AP; Agrawal N; Brierley JD; Duvvuri U; Ferris RL; Genden E; Wong RJ; Tuttle RM; Lee NY; Randolph GW
    Head Neck; 2016 Apr; 38(4):493-8. PubMed ID: 26716601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial.
    Chen J; Ji Q; Bai C; Zheng X; Zhang Y; Shi F; Li X; Tang P; Xu Z; Huang R; Huang T; Pan Y; Fan S; Zhou J; Su W
    Thyroid; 2020 Sep; 30(9):1245-1253. PubMed ID: 32075524
    [No Abstract]   [Full Text] [Related]  

  • 29. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K
    Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy.
    Jin M; Megwalu UC; Noel JE
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):97-103. PubMed ID: 32746731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current role of adjuvant radiotherapy in management of medullary thyroid carcinoma: A single institute analysis.
    Bhuvana J; Shivhare V; Rath S; Parikh A; Kunikullaya US
    J Cancer Res Ther; 2024 Aug; ():. PubMed ID: 39207088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiotherapy in well-differentiated thyroid cancer: is it underutilized?
    So K; Smith RE; Davis SR
    ANZ J Surg; 2016 Sep; 86(9):696-700. PubMed ID: 26573999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative radioactive iodine-131 ablation is not necessary among patients with intermediate-risk differentiated thyroid carcinoma: a population-based study.
    Zhang H; Cai Y; Zheng L; Zhang Z; Jiang N
    Hell J Nucl Med; 2017; 20(1):3-10. PubMed ID: 28315902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
    Panigrahi B; Roman SA; Sosa JA
    Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC).
    Lodi Rizzini E; Repaci A; Tabacchi E; Zanoni L; Vicennati V; Cavicchi O; Pagotto U; Morganti AG; Fanti S; Monari F
    Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of adjuvant external beam radiotherapy for papillary thyroid cancer based on competitive risk model and propensity score matching.
    Zhou J; Wu C; Fan S; Zhao M
    Sci Rep; 2023 Apr; 13(1):6925. PubMed ID: 37117278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008.
    Sacks W; Fung CH; Chang JT; Waxman A; Braunstein GD
    Thyroid; 2010 Nov; 20(11):1235-45. PubMed ID: 21062195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin.
    Watanabe K; Igarashi T; Uchiyama M; Ojiri H
    Ann Nucl Med; 2020 Dec; 34(12):920-925. PubMed ID: 32940889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External Beam Radiation in Differentiated Thyroid Carcinoma.
    Billan S; Charas T
    Rambam Maimonides Med J; 2016 Jan; 7(1):. PubMed ID: 26886956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.